BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reichardt P. The treatment of uterine sarcomas. Annals of Oncology 2012;23:x151-7. [DOI: 10.1093/annonc/mds359] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Yu HY, Jin YL. Metastatic low-grade endometrial stromal sarcoma with variable morphologies in the ovaries and mesentery: A case report. World J Clin Cases 2022; 10(23): 8384-8391 [DOI: 10.12998/wjcc.v10.i23.8384] [Reference Citation Analysis]
2 Borella F, Bertero L, Cassoni P, Piovano E, Gallio N, Preti M, Cosma S, Ferraioli D, Pace L, Mariani L, Biglia N, Benedetto C. Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. Front Oncol 2022;12:883344. [DOI: 10.3389/fonc.2022.883344] [Reference Citation Analysis]
3 Boșoteanu M, Vodă RI, Așchie M, Bosoteanu L, Bălțătescu GI. Morphological and Ancillary Features of Uterine Leiomyosarcoma: Case Report. Clin Med�Insights�Pathol 2022;15:2632010X2211052. [DOI: 10.1177/2632010x221105224] [Reference Citation Analysis]
4 Mishra J, Bhattacharya S, Pandia A, Padhy A, Mahapatra M, Mohapatra J. Leiomyosarcoma of Uterus in a Nulliparous Female: Mimicking as Ovarian Malignancy. Asian Journal of Oncology 2021;07:156-9. [DOI: 10.1055/s-0041-1730098] [Reference Citation Analysis]
5 Kyriazoglou A, Liontos M, Ntanasis-Stathopoulos I, Gavriatopoulou M. The systemic treatment of uterine leiomyosarcomas: A systematic review. No news is good news? Medicine (Baltimore) 2021;100:e25309. [PMID: 33787622 DOI: 10.1097/MD.0000000000025309] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Wang X, Han Y, Li J, Hong D, Xue Z, Huang H, Du Z, Hou Y, Li H, Li H, Liao H, Xie X, Ding C. Multi-omics analysis of copy number variations of RNA regulatory genes in soft tissue sarcoma. Life Sci 2021;265:118734. [PMID: 33166590 DOI: 10.1016/j.lfs.2020.118734] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
7 Xie HP, Peng SH, Yi WM, Wang FL, Wu WK. Natural Pregnancy and Successful Delivery in A Woman with Endometrial Stromal Sarcoma After Sequential Therapy with Heavy Dosage of Chinese Medicine: A Case Report. Chin J Integr Med. 2020;26:783-785. [PMID: 32146593 DOI: 10.1007/s11655-020-3251-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Thangappah RBP. Uterine Sarcoma: A Clinico-Pathological Study. J Obstet Gynaecol India 2019;69:147-52. [PMID: 31686748 DOI: 10.1007/s13224-018-1141-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Wang M, Meng SH, Li B, He Y, Wu YM. Survival outcomes of different treatment modalities in patients with low-grade endometrial stromal sarcoma. Chin Med J (Engl) 2019;132:1128-32. [PMID: 30985313 DOI: 10.1097/CM9.0000000000000259] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Cao H, Li L, Yang B, Luo G, Lou J, Xi M. Unexpected uterine sarcomas after hysterectomy and myomectomy for presumed leiomyoma: a retrospective study of 26,643 patients. Cancer Manag Res 2019;11:7007-14. [PMID: 31440089 DOI: 10.2147/CMAR.S208405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
11 Li Y, Ren H, Wang J. Outcome of adjuvant radiotherapy after total hysterectomy in patients with uterine leiomyosarcoma or carcinosarcoma: a SEER-based study. BMC Cancer 2019;19:697. [PMID: 31307426 DOI: 10.1186/s12885-019-5879-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
12 Gonzalez Dos Anjos L, de Almeida BC, Gomes de Almeida T, Mourão Lavorato Rocha A, De Nardo Maffazioli G, Soares FA, Werneck da Cunha I, Baracat EC, Carvalho KC. Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment? Cancers (Basel) 2018;10:E315. [PMID: 30200635 DOI: 10.3390/cancers10090315] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
13 Odei B, Boothe D, Suneja G, Werner TL, Gaffney DK. Chemoradiation Versus Chemotherapy in Uterine Carcinosarcoma: Patterns of Care and Impact on Overall Survival. American Journal of Clinical Oncology 2018;41:784-91. [DOI: 10.1097/coc.0000000000000360] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
14 Chang CC, Huang LH, Chiang W, Hsia SM. Hexane fraction of adlay (Coix lachryma-jobi L.) testa ethanolic extract inhibits human uterine sarcoma cancer cells growth and chemosensitizes human uterine sarcoma cells to doxorubicin. Phytomedicine 2018;47:69-80. [PMID: 30166110 DOI: 10.1016/j.phymed.2018.03.056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
15 Tong X, Wang X, Wang C, Li L. Elevated levels of serum MiR-152 and miR-24 in uterine sarcoma: potential for inducing autophagy via SIRT1 and deacetylated LC3. Br J Biomed Sci 2018;75:7-12. [PMID: 28929922 DOI: 10.1080/09674845.2017.1340225] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
16 Agarwal R, Rajanbabu A, Nair IR, Satish C, Jose G, Unikrishnan U. Endometrial stromal sarcoma—A retropsective analysis of factors affecting recurrence. European Journal of Obstetrics & Gynecology and Reproductive Biology 2017;216:92-7. [DOI: 10.1016/j.ejogrb.2017.07.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
17 Agah J, Karimzadeh S, Moharrer Ahmadi F. Misdiagnosis of a Giant Uterine Leiomyosarcoma: Clinic and Image Challenges. Case Rep Oncol Med 2017;2017:3568328. [PMID: 28804663 DOI: 10.1155/2017/3568328] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Lee JS, Ahn C, Kang HY, Jeung EB. Effect of 2-methoxyestradiol on SK-LMS-1 uterine leiomyosarcoma cells. Oncol Lett 2017;14:103-10. [PMID: 28693141 DOI: 10.3892/ol.2017.6165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhan L, Tang J, Sun M, Qin C. Animal Models for Tuberculosis in Translational and Precision Medicine. Front Microbiol 2017;8:717. [PMID: 28522990 DOI: 10.3389/fmicb.2017.00717] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
20 Martin-Romano P, Jurado M, Idoate MA, Arbea L, Hernandez-Lizoain JL, Cano D, Paramo JA, Martin-Algarra S. Durable complete remission with aromatase inhibitor therapy in a patient with metastatic uterine carcinosarcoma with poor performance status and coagulation disorders: a case report. J Med Case Rep 2017;11:115. [PMID: 28424084 DOI: 10.1186/s13256-017-1262-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
21 Cui RR, Wright JD, Hou JY. Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome. BJOG 2017;124:1028-37. [PMID: 28128524 DOI: 10.1111/1471-0528.14579] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
22 Vesela E, Chroma K, Turi Z, Mistrik M. Common Chemical Inductors of Replication Stress:  Focus on Cell-Based Studies. Biomolecules 2017;7:E19. [PMID: 28230817 DOI: 10.3390/biom7010019] [Cited by in Crossref: 41] [Cited by in F6Publishing: 14] [Article Influence: 8.2] [Reference Citation Analysis]
23 Lee SW, Lee TS, Hong DG, No JH, Park DC, Bae JM, Seong SJ, Shin SJ, Ju W, Lee KH, Lee YK, Cho H, Lee C, Paek J, Kim HJ, Lee JW, Kim JW, Bae DS. Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement. J Gynecol Oncol 2017;28:e12. [PMID: 27894165 DOI: 10.3802/jgo.2017.28.e12] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
24 Suh DS, Kim YH, Yun KY, Lee NK, Choi KU, Kim KH, Yoon MS. An unusual case of pedunculated subserosal leiomyosarcoma of the uterus mimicking ovarian carcinoma. J Ovarian Res 2016;9:2. [PMID: 26857119 DOI: 10.1186/s13048-016-0212-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
25 Lange SE, Liu J, Adkins DR, Powell MA, Van Tine BA, Mutch DG. Improved clinical trial enrollments for uterine leiomyosarcoma patients after gynecologic oncology partnership with a sarcoma center. Gynecol Oncol 2016;140:307-12. [PMID: 26718726 DOI: 10.1016/j.ygyno.2015.12.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
26 Pistilli A, Rende M, Crispoltoni L, Montagnoli C, Stabile AM. LY294002 induces in vitro apoptosis and overexpression of p75NTR in human uterine leiomyosarcoma HTB 114 cells. Growth Factors 2015;33:376-83. [DOI: 10.3109/08977194.2015.1118096] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
27 Strong MJ, Rosenlof T, Padmanabha S, Weiner RS, Morgan LR, Ware MI. Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy. J Neurosurg Spine 2015;23:607-12. [PMID: 26186448 DOI: 10.3171/2015.1.SPINE14640] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
28 Thanopoulou E, Aleksic A, Thway K, Khabra K, Judson I. Hormonal treatments in metastatic endometrial stromal sarcomas: the 10-year experience of the sarcoma unit of Royal Marsden Hospital. Clin Sarcoma Res 2015;5:8. [PMID: 25810898 DOI: 10.1186/s13569-015-0024-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
29 Tanos V, Brölmann H, Dewilde RL, O’donovan P, Campo R. Myoma morcellation and leiomyosarcoma panic. Gynecol Surg 2015;12:17-9. [DOI: 10.1007/s10397-014-0876-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kaur K, Kaur P, Kaur A, Singla A. Uterine leiomyosarcoma: A case report. J Midlife Health 2014;5:202-4. [PMID: 25540573 DOI: 10.4103/0976-7800.145175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Philip C, Pautier P, Duffaud F, Ray-coquard I. High-Grade Undifferentiated Sarcomas of the Uterus: Diagnosis, Outcomes, and New Treatment Approaches. Curr Oncol Rep 2014;16. [DOI: 10.1007/s11912-014-0405-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
32 Martin-Liberal J, Benson C, Messiou C, Fisher C, Judson I. Reversion of Hormone Treatment Resistance with the Addition of an mTOR Inhibitor in Endometrial Stromal Sarcoma. Case Rep Med 2014;2014:612496. [PMID: 25104960 DOI: 10.1155/2014/612496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
33 Reed N. A review of treatment of uterine leiomyosarcomas. Curr Oncol Rep 2013;15:581-7. [PMID: 24136566 DOI: 10.1007/s11912-013-0350-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
34 Seagle BL, Falter KJ 2nd, Lee SJ, Frimer M, Samuelson R, Shahabi S. Mullerian adenosarcoma of the cervix: Report of two large tumors with sarcomatous overgrowth or heterologous elements. Gynecol Oncol Case Rep 2014;9:7-10. [PMID: 25426405 DOI: 10.1016/j.gynor.2014.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 Fröhlich LF, Mrakovcic M, Smole C, Lahiri P, Zatloukal K. Epigenetic silencing of apoptosis-inducing gene expression can be efficiently overcome by combined SAHA and TRAIL treatment in uterine sarcoma cells. PLoS One 2014;9:e91558. [PMID: 24618889 DOI: 10.1371/journal.pone.0091558] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
36 Jimenez WA, Sardi A, Nieroda C, Gushchin V. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of recurrent high-grade uterine sarcoma with peritoneal dissemination. Am J Obstet Gynecol 2014;210:259.e1-8. [PMID: 24211479 DOI: 10.1016/j.ajog.2013.11.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
37 Yoon A, Park J, Park J, Lee Y, Kim T, Choi CH, Bae D, Kim B, Lee J, Nam J. Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: A multicenter review of 114 cases. Gynecologic Oncology 2014;132:70-5. [DOI: 10.1016/j.ygyno.2013.10.029] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
38 Jain NX, Morgan M, Corbo J, Sharma A, Van Stavern GP. Diplopia with a Cavernous Sinus Metastasis of a Remote Endometrial Stromal Tumour. Neuroophthalmology 2013;37:204-8. [PMID: 28167989 DOI: 10.3109/01658107.2013.809367] [Reference Citation Analysis]
39 Cassier PA, Lefranc A, Amela EY, Chevreau C, Bui BN, Lecesne A, Ray-Coquard I, Chabaud S, Penel N, Berge Y. A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group. Br J Cancer. 2013;109:909-914. [PMID: 23922114 DOI: 10.1038/bjc.2013.442] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
40 Martin-Liberal J, Benson C. Systemic chemotherapy for inoperable, locally advanced, recurrent or metastatic uterine leiomyosarcoma. Clin Oncol (R Coll Radiol) 2013;25:343-5. [PMID: 23507441 DOI: 10.1016/j.clon.2013.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]